We use cookies to give you the best possible experience on our website.




Mini Plate Reader Wins 5K for Excellence in Innovation from CIMIT’s CRAASH Course

Mini Plate Reader Wins 5K for Excellence in Innovation from CIMIT’s CRAASH Course

On July 14, 2016, CIMIT completed the third session of the CRAASH program, a course focusing on innovation in the healthtech space. Six teams presented final pitches at the end of the intensive 10-week program. Team “Mini Plate Reader” was a highlight among the six projects this semester.

Mini Plate Reader has developed the world’s first multiwell plate reader for anaerobic environments designed to help scientists more easily and cost effectively conduct research, took home CIMIT’s Award for Excellence in Innovation based on feedback from course accelerator executives and fellow peers.

“We are developing technology that we hope will enable radical changes in how cellular growth is measured,” says Jason Papin from Team Mini Plate Reader. “The CRAASH course and the fantastic mentorship from our Accelerator Executive helped us to crystallize our value propositions and business plans. Our team learned a tremendous amount from the CRAASH community.”

“It was great to see the value proposition evolve and solidify during the course and, as a result, a clear focus on a niche market from which the business could be built and expanded,” said Paul Tessier, CIMIT Accelerator Executive. “The team came a long way and are off to a great start to create a business.”

Other projects during the spring session also included a point-of-care platform that can test a single drop of blood and return results in less than 5 minutes, a portable and customizable microfluidic pump, a non-invasive device that directly measures iron stores, a novel needle to improve bone marrow aspiration yields with less pain, and a platform to improve the safety and quality of x-ray exams.

The next CRAASH session is scheduled for this winter. Learn more about how you can get involved with the CRAASH course here.

No comments yet. Be the first.


Avoiding Deal Killers

In today’s environment, even promising healthech innovations fail to get investments from financially motivated investors. As a result, solutions do not survive the so-called Valley of Death. There are numerous good reasons why investors choose not to invest. In many cases, it is because the innovator did not anticipate and prepare a response to a question about a particular risk. This can be traced back to the fact that innovators often fail to put themselves in an investor’s shoes. Doing so is critical to understanding why they may not invest in their solution—the “deal killers”.

Read More »

National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network

This paper describes the POCTRN and the three currently funded Centers as examples of academic-based organizations that support  collaborations across disciplines, institutions, and geographic regions to successfully drive innovative solutions from concept to patient care.

Read More »

Healthcare Commercialization Programs

Healthcare commercialization programs (HCPs) are described and proposed as an option that institutions can add to their portfolio to improve translational research. In helping teams translate specifc healthcare innovations into practice, HCPs expand the skillset of investigators and enhance an institution's innovation capacity. Lessons learned are shared from configuring and delivering HCPs, which build on the fundamentals of the National Science Foundation's Innovation Corps program, to address the unique challenges in supporting healthcare innovations and innovators.

Read More »

2014 CIMIT Clinical Impact Study Update

This is an ongoing, work-in-process update of CIMIT’s Clinical Impact Study (CIS). First conducted in 2009, the CIS is a self-assessment by CIMIT faculty and investigators of its project portfolio and Accelerator Program and now includes projects initiated between 1998 and 2012. The innovation portfolio, an important subset of the ways in which CIMIT helps speed innovations into patient care, represents an investment of almost $70M over 14 years. It also represents a rather unique longitudinal set of experiences from which to learn.

Read More »

IEEE Pulse Featuring CIMIT

If ever an industry was in need of both incremental and disruptive innovation it is today's health care industry. Realizing the full potential of innovation across the spectrum of health care environments is critical to address the well-documented, emerging global crisis generated by the aging of the population, the obligation to increase access for all to the best standard of care, and the societal imperative to contain costs.

Read More »

Facilitating Translational Research

Would a carpenter be asked to manage building a new housing development? Probably not. More likely a real estate developer with the skills, experience and knowledge of the local market and trades, including carpentry, would manage such an undertaking. Good developers anticipate and address the challenges of building and selling homes. Delivering attractive appropriately priced homes on time and on budget requires that developers use their knowledge, experience, and judgment to make numerous decisions that engage the right talent at the right time to balance development risks and costs.

Read More »

Venture Findings Featuring the CIMIT Model

The Consortia for Improving Medicine with Innovation & Technology (CIMIT) was established in 1998 by four leading academic medical centers and universities in the greater Boston area to leverage the value of a consortium to improve patient care through Deep Innovation using medical technology to solve pressing unmet medical needs.

Read More »